FinnvedenBulten’s Full Year Report 2013 Good finish to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FinnvedenBulten’s Full Year Report 2013

Good finish to 2013, strong order bookings and unchanged dividend FOURTH QUARTER · Net sales reached SEK 823 million (677), up 21.6% on the same period last year. · Earnings (EBIT) adjusted for non-recurring items were SEK 45 million (11), which corresponds to an adjusted operating margin of 5.4% (1.7). · Earnings (EBIT) reached SEK 41 million (11), which corresponds to an operating margin of 4.9% (1.7). · Earnings after tax was SEK 29 million (-15) and SEK 32 million (4) when adjusted for non-recurring costs for the restructuring programme and in 2012 due to changed tax rate in Sweden. · Order bookings amounted to SEK 925 million (578), up 60.1% on the same period last year. · Cash flow from current activities was SEK 86 million (44). · Earnings per share were SEK 1.37 (-0.70). Adjusted for non-recurring items, earnings per share were SEK 1.51 (0.21). · FinnvedenBulten won new business worth an annual amount of around SEK 240 million. JANUARY - DECEMBER · Net sales reached SEK 3,061 million (2,963), up 3.3% on the same period last year. · Earnings adjusted for non-recurring items were SEK 144 million (103), which corresponds to an adjusted operating margin of 4.7% (3.5). · Earnings (EBIT) reached SEK 105 million (103), which corresponds to an operating margin of 3.4% (3.5). · Profit after tax was SEK 88 million (43) and SEK 91 million (63) when adjusted for non-recurring items of SEK 3 million net comprising a tax receivable from an approved interest deduction resulting from the verdict of the Swedish Administrative Court of Appeal SEK 27 million and restructuring costs SEK –30 million. Earnings after tax last year were affected by SEK -19 million due to a change in the Swedish tax rate. · Order bookings amounted to SEK 3,266 million (2,833), up 15.3% on the same period last year. · Cash flow from current activities was SEK 219 million (72). · Earnings per share were SEK 4.19 (2.07). Adjusted for non-recurring items, earnings per share were SEK 4.35 (2.98). · The Board proposes an unchanged dividend of SEK 2.00 per share. IMPORTANT EVENTS AFTER THE END OF THE REPORTING PERIOD · FinnvedenBulten has signed an agreement concerning the sale of the Swedish aluminium business at Finnveden Gjutal AB within the Finnveden Metal Structures division. The transaction is expected to be completed in Q1, 2014. “The Group’s operating earnings were strengthened during the year due to higher volumes and the effects of the ongoing restructuring. Demand has improved steadily and the positive trends continued into the final quarter. During the final quarter FinnvedenBulten won additional significant contracts worth approximately SEK 240 million annually, of which most was within the Bulten division. Our successful FSP concept (Full Service Provider) within division Bulten continues to generate market shares and the new contracts will mean gradual volume increases in coming years with relatively limited start-up costs. Profitability for Finnveden Metal Structures improved due to higher volumes combined with restructuring. Implementation of the decision to focus magnesium casting in Poland is progressing well and an agreement concerning the sale of the aluminium business was signed after the end of the period. To further improve business focus and clarify the value in each division, the Board and management have initiated an evaluation of a split of the Group during 2014. The aim of this evaluation is to optimise the divisions’ future opportunities and to achieve long-term added value for shareholders.” Johan Westman, President and CEO Investors, analysts and media are invited to participate in the teleconference on Thursday, February 6 at 15:30 CET when the report will be presented by FinnvedenBulten’s President and CEO Johan Westman. Additional participants from the company are Executive Vice President Tommy Andersson and CFO Helena Wennerström. Copies of the presentation will be available on www.finnvedenbulten.com approximately 30 minutes before the conference starts. The full report is attached to this press release. To participate, please call 5 minutes before the opening of the conference call to Sweden +46 8 506 443 86, UK +44 207 153 9154, US +1 877 423 0830. Code: 275868#. A replay of the telephone conference is available until February 20, 2014 on the phone numbers Sweden +46 8-505 564 73, UK +44 203 364 5200, USA +1 877 679 2989. Code: 349967#. For further information, please contact: Johan Westman, President and CEO Tel: + 46 31-734 59 00 Kamilla Oresvärd, Vice President Corporate Communications Tel: +46 70-520 59 17, e-mail: kamilla.oresvard@finnvedenbulten.com NB: The information in this announcement is required to be disclosed by FinnvedenBulten AB (publ) under the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 13:30 CET on February 6, 2014. FinnvedenBulten develops and manages industrial businesses, offering products, technical solutions and systems in metallic materials. The Group operates as a business partner to international customers in the engineering industry, primarily the automotive industry. FinnvedenBulten is structured into two divisions – Bulten and Finnveden Metal Structures – both with strong positions in their respective customer segments. FinnvedenBulten is listed on NASDAQ OMX Stockholm. Further information at www.finnvedenbulten.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VeriSilicon's GLTiny: Game-Changer for Wearable Tech

Updated Category News Views 58

Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 109

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
Guidewire's 2026 Awards Highlight AI in Insurance Shift

Updated Category News Views 44

AI Takes Center Stage at Guidewire's Annual Gala Change is constant, but when it comes with a potent mix of AI and insurance, you know things are about to get interesting. Guidewire Software (NYSE: GWRE) is tipping its hat to Beazley, Definity, and RCIS, the standouts at its annual Innovation Awards. Held during their CONNECTIONS Conference in Las Vegas, this year's...

Continue Reading
UPM's WISA Group Demerger: A Strategic Shift

Updated Category News Views 136

UPM's Bold Move on the Chessboard In a market that's no stranger to seismic tremors, UPM's decision to move forward with the partial demerger of its Kymmene Corporation is something that raises a few eyebrows. But hey, isn't shaking things up half the fun in this business? The Finnish Financial Supervisory Authority giving a thumbs-up to the supplement listing for WISA...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 152

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading
United Imaging Surges with 19.43% Revenue Growth in 2026

Updated Category News Views 0

United Imaging's Remarkable Revenue Surge Coming out of Shanghai, we've got some major numbers to chew on. United Imaging Healthcare (688271.SH)—this isn't your run-of-the-mill medical tech firm—is bringing some serious heat to the market with a 19.43% bump in revenue. We're talking RMB 10.58 billion raked in over just the first nine months of 2026. Those are hefty...

Continue Reading
Beta Bionics: Investors on Edge, Legal Moves Underway

Updated Category News Views 73

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 65

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
MGM China Hits Record Highs Amid Market Challenges

Updated Category News Views 59

Highs Amid Headwinds: MGM China's Standout Quarter Rolling into one's portfolio, MGM China isn't just coasting along—it's smashing some records, despite fierce headwinds. It's not all smooth sailing in Macau's gaming scene, but MGM China has hammered out its third-quarter results with gusto, setting new records for revenue and adjusted EBITDA. These folks aren't just...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 206

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
=2">More News Articles